Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Robb M. Stewart Argonaut Gold's production last year narrowly missed its target after the ramp up of the mine and mill at its flagship Magino operation...
(Article 223-16 of General Regulation of the French financial markets authority)...
Healthcare industry professionals scored cell and gene therapy (CGT) as the industry trend to have the greatest impact on the pharmaceutical industry in 2024, in a recent survey launched by data and analytics firm GlobalData.
South Korea has issued guidelines to monitor the side effects of the two approved CAR-T therapies – Kymriah from Novartis and Carvykti from Janssen.
CASI Pharmaceuticals and Juventas Cell Therapy recently received approval from China's National Medical Products Administration (NMPA) for Yuanruida, a domestic CD19-targeting CAR-T therapy for relapsed/refractory B-Cell Acute Lymphocytic Leukemia.